Kalevi Kurkijärvi

Bio

Dr Kurkijärvi is a founding partner of Bio Fund Management Oy Ltd and has been the chairman of the board since the founding of the company. In addition to his service on the board, funding work, and investor relations, he is in charge of finding investment targets, especially, in the pharmaceuticals industry. He serves or has served as a chairman of the board at BioTie Therapies Corp, MAP Medical Oy, Bio Orbit Oy, Admin Technologies Oy, FibroGen Europe Oy, Pribori Oy, Hormos Medical Oy, Hytest Oy and Rados Technology Oy. He also is and has been on boards of directors of more than 20 international life science companies among others: Ark Therapeutics Ltd (UK), FibroGen Inc (US), Paratek Pharmaceuticals Inc (US), A+ Science AB (Sweden), Aboa Tech Oy and Juvantia Pharma Ltd. Prior to founding of BioFund, Dr Kurkijärvi was director of venture capital group, Finnish National Fund of Research and Development Sitra. He has also served as executive vice president at Wallac Oy and as CEO at Pharmacia Diagnostics Production Oy. He also worked for several years as a researcher and teacher at the University of Turku, publishing several scientific papers during that time.